Background and Objectives: Irreversible visual impairment is mainly caused by retinal degenerative diseases such as age-related macular degeneration and retinitis pigmentosa. Stem cell research has experienced rapid progress in recent years, and researchers and clinical ophthalmologists are trying to implement this promising technology to treat retinal degeneration. The objective of this systematic review is to analyze currently available data from clinical trials applying stem cells to treat human retinal diseases. Materials and Methods: We performed a systematic literature search in PubMed to identify articles related with stem cell therapies to retinal diseases published prior to September 2021. Furthermore, a systematic search in ClinicalTrials (NIH U.S. National Library of Medicine) was performed to identify clinical trials using stem cells to treat retinal diseases. A descriptive analysis of status, conditions, phases, interventions, and outcomes is presented here. Conclusions: To date, no available therapy based on stem cell transplantation is approved for use with patients. However, numerous clinical trials are currently finishing their initial phases and, in general, the outcomes related to implantation techniques and their long-term safety seem promising. In the next few years, we expect to see quantifiable results pertaining to visual function improvement.
Isotretinoin is a vitamin A derivative used as a first-line treatment for moderate to severe acne. One of its most frequent side effects is dry eye disease (DED), in which tear film instability and neurosensory abnormalities play an etiologic role. The purpose of this research was to analyze changes in corneal innervation and its association with tear film integrity in patients treated with oral isotretinoin. Twenty-eight patients treated with oral isotretinoin and the same number of age and sex distribution-matched healthy volunteers were included in this observational case‒control study. They were examined by in vivo corneal confocal microscopy (IVCM) to quantify the corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), corneal nerve fiber length (CNFL), and corneal nerve fractal dimension (CNFrD) in addition to the presence of dendritiform cells, microneuromas, and visibility of axonal beadings. Tear film analysis was also performed, as was the perception of discomfort related to ocular surface disease. The results of the comparative analysis of the isotretinoin group vs. the control group (mean [standard error]) were as follows: CNFD 18.57 [1.67] vs. 24. 57 [1.55] fibers per mm2 (p = 0.01); CNBD 19.05 [2.43] vs. 30.62 [3.53] branches per mm2 (p = 0.02); CNFL 13.90 [1.01] vs. 14.64 [0.66] mm per mm2 (p = 0.54); CNFrD 1.46 [0.005] vs. 1.49 [0.006] (p = 0.01); Schirmer test 5.7 [1.1] vs. 10.3 [0.5] millimeters (p < 0.001). The break-up time (BUT) was 5.70 [0.6] vs. 11.2 [0.2] seconds (p < 0.001). A linear regression equation model was developed for BUT (R2 = 0.48; 1-β = 0.98; p = 0.01) and CNFrD (R2 = 0.58; 1-β = 0.99; p = 0.002). Oral isotretinoin treatment promotes a vicious cycle of ocular surface disease that leads to damage to the subbasal nerve plexus. This damage increases with treatment time and impacts basal tear production.
(1) Background: Abnormal corneal wound healing compromises visual acuity and can lead to neuropathic pain. Conventional treatments usually fail to restore the injured corneal tissue. In this study, we evaluated the effectiveness of a synthetic heparan sulfate mimetic polymer (HSmP) in a mouse model of corneal wound healing. (2) Methods: A surgical laser ablation affecting the central cornea and subbasal nerve plexus of mice was used as a model of the wound-healing assay. Topical treatment with HSmP was contrasted to its vehicle and a negative control (BSS). Corneal repair was studied using immunofluorescence to cell proliferation (Ki67), apoptosis (TUNEL assay), myofibroblast transformation (αSMA), assembly of epithelial cells (E-cadherin) and nerve regeneration (β-tubulin III). (3) Results: At the end of the treatment, normal epithelial cytoarchitecture and corneal thickness were achieved in HSmP-treated animals. HSmP treatment reduced myofibroblast occurrence compared to eyes irrigated with vehicle (p < 0.01) or BSS (p < 0.001). The HSmP group showed 50% more intraepithelial nerves than the BSS or vehicle groups. Only HSmP-treated corneas improved the visual quality to near transparent. (4) Conclusions: These results suggest that HSmP facilitates the regeneration of the corneal epithelium and innervation, as well as restoring transparency and reducing myofibroblast scarring after laser experimental injury.
Corneal diseases are a major cause of vision loss, often associated with aging, trauma and disease. Damage to corneal sensory innervation leads to discomfort and pain. Environmental stressors, such as short-wavelength light, can induce oxidative stress that alters mitochondrial function and affects cell and tissue homeostasis, including corneal innervation. Cellular antioxidant mechanisms may attenuate oxidative stress. This study investigates crocin, a derivative of saffron, as a potential antioxidant therapy. In vitro rat trigeminal sensory ganglion neurons were exposed to both sodium azide and blue light overexposure as a model of oxidative damage. Crocin was used as a neuroprotective agent. Mitochondrial and cytoskeletal markers were studied by immunofluorescence analysis to determine oxidative damage and neuroprotection. In vivo corneal innervation degeneration was evaluated in cornea whole mount preparations using Sholl analyses. Blue light exposure induces oxidative stress that affects trigeminal neuron mitochondria and alters sensory axon dynamics in vitro, and it also affects corneal sensory innervation in an in vivo model. Our results show that crocin was effective in preserving mitochondrial function and protecting corneal sensory neurons from oxidative stress. Crocin appears to be a promising candidate for the neuroprotection of corneal innervation.
Proteoglycans (PGs) and their glycosaminoglycan (GAG) chains play key roles in corneal epithelial physiology and host–microbe interactions. Although bacterial exposure has been shown to alter PG and GAG biosynthesis, the contribution of specific bacterial-derived signals remains unclear. In this study, reconstructed human corneal epithelia (QobuR) were exposed to bacterial extracellular vesicles (BEVs) from Pseudomonas aeruginosa and Staphylococcus epidermidis, as well as to lipopolysaccharide, peptidoglycan, and lipoteichoic acid. The expression of 72 genes involved in PG and GAG biosynthesis and remodeling was analyzed by quantitative real-time PCR. Only 22 genes showed significant transcriptional alterations, indicating a highly selective response. Most changes affected enzymes involved in the generation of heparan sulfate (HS) and chondroitin sulfate (CS) fine structure, particularly sulfotransferases. Notably, HS3ST4 and HS3ST5 were consistently upregulated under all experimental conditions, suggesting that modulation of HS 3-O-sulfation represents a conserved corneal epithelial response to bacterial-derived stimuli. Whereas microbial-associated molecular patterns induced broader transcriptional responses, BEVs elicited more restricted and species-dependent effects. Overall, these findings demonstrate that bacterial-derived signals selectively remodel GAG biosynthetic pathways and provide new insights into the molecular mechanisms underlying host–microbe interactions at the ocular surface.
About Me
Biologist. Master in Neuroscience Research and Master in Biomedicine and Molecular Oncology. PhD.
Biologist. Master in Neuroscience Research and Master in Biomedicine and Molecular Oncology. PhD.